Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Science|April 22, 2020
Tyrosine kinase inhibitors induce alternative spliced BCR-ABLIns35bp variant via inhibition of RNA polymerase II on genomic BCR-ABLJunichiro Yuda, Jun Odawara, Mariko Minami, et al.
International Journal of Hematology|September 26, 2018
Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantationSatoshi Yamasaki, Goichi Yoshimoto, Kentaro Kohno, et al.
Cancer Science|December 22, 2005
Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate ((90)Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphomaTakashi Watanabe, Shoji Terui, Kuniaki Itoh, et al.
Internal Medicine (Tokyo, Japan)|May 16, 2014
Successful treatment of invasive zygomycosis based on a prompt diagnosis using molecular methods in a patient with acute myelogenous leukemiaJunichiro Yuda, Koji Kato, Yoshikane Kikushige, et al.
Cancer Science|May 13, 2009
Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximabKensei Tobinai, Takashi Watanabe, Kazuki Tanimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 25, 2011
[Therapeutic choice for the chronic myeloid leukemia patients in chronic phase showing late suboptimal response to imatinib]Itaru Matsumura, Yasuhito Nannya, Tadashi Nagai, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 7, 2025
Adverse events during preoperative autologous blood donation and its usage in obstetrical patients: A multicenter, retrospective survey in JapanAkihiko Yokohama, Hiroshi Fujita, Kazuhiro Nagai, et al.
European Journal of Haematology|March 7, 2025
Clinical Impact of Continuous Dasatinib Administration on the Prognosis of Patients With BCR::ABL1 Acute Lymphoblastic Leukemia: Result of the Prospective MRD2014 Study Conducted by Fukuoka Blood and Marrow Transplantation Group (FBMTG)Koji Nagafuji, Yoshikiyo Ito, Toshihiro Miyamoto, et al.
Blood Neoplasia|June 23, 2025
Augmented use of L-asparaginase markedly improves AYA ALL outcomes: FBMTG prospective MRD2014 studyKoji Nagafuji, Toshihiro Miyamoto, Tetsuya Eto, et al.
International Journal of Hematology|December 1, 2025
Comparison of quantitative PCR values and antigenemia for CMV monitoring in hematopoietic cell transplant recipientsYasuo Mori, Kentaro Kohno, Toshiyuki Ueno, et al.
Pageof 5